HARVEST MANAGEMENT LLC
Reported holdings as of Q2 2026, from 31 quarterly filings.
Holdings
| Security | Ticker | Value | Shares | Weight | Weight change | Held | Change |
|---|---|---|---|---|---|---|---|
| ELECTRONIC ARTS INC | EA | $40.9M | 199,500 | -2.09pp | 4q | +8.5%+$3.2M | |
| WARNER BROS DISCOVERY INC OPT | WBD | $24.0M | 435,166 | -1.79pp | 4q | -4.8%-$1.2M | |
| TOPBUILD COR | BLD | $18.6M | 43,692 | - | new | NEW | |
| JANUS HENDERSON GROUP PLC | JHG | $18.2M | 349,500 | -0.83pp | 2q | +12.7%+$2.1M | |
| PENUMBRA INC | PEN | $18.2M | 57,487 | +4.27pp | 2q | +219.4%+$12.5M | |
| TAYLOR MORRISON HOME CORP | TMHC | $18.1M | 252,500 | - | new | NEW | |
| NORFOLK SOUTHN CORP | NSC | $15.8M | 50,300 | -3.88pp | 4q | -30.7%-$7.0M | |
| NUVALENT INC OPT | NUVL | $13.1M | 36,000 | - | new | NEW | |
| BIO-TECHNE CORP | TECH | $12.0M | 170,000 | - | new | NEW | |
| CHART INDS INC | GTLS | $11.1M | 53,000 | - | new | NEW | |
| APOGEE THERAPEUTICS INC | APGE | $10.5M | 79,000 | - | new | NEW | |
| CATALYST PHARMACEUTICALS INC | CPRX | $4.7M | 150,000 | - | new | NEW | |
| PARAMOUNT SKYDANCE CORP OPT | PSKY | $4.3M | 282,795 | +1.45pp | 4q | +371.3%+$3.4M | |
| SKYWATER TECHNOLOGY INC | SKYT | $4.0M | 115,288 | +0.89pp | 2q | +123.4%+$2.2M | |
| WEBSTER FINL CORP | WBS | $3.5M | 46,100 | -0.08pp | 2q | +6.0%+$198.7K | |
| SILA REALTY TRUST INC | SILA | $3.2M | 105,900 | - | new | NEW | |
| QXO INC OPT | QXO | $2.4M | options only | - | new | OPTIONS | |
| BEAZER HOMES USA INC | BZH | $2.2M | 80,000 | - | new | NEW | |
| LIVERAMP HLDGS INC OPT | RAMP | $2.2M | 30,000 | - | new | NEW | |
| ORGANON & CO | OGN | $2.2M | 158,800 | - | new | NEW | |
| MGM RESORTS INTERNATIONAL | MGM | $2.0M | 42,000 | - | new | NEW | |
| TWO HARBORS INVENTMENT CORPO | TWO | $1.8M | 141,573 | -0.42pp | 2q | -29.2%-$725.1K | |
| UNIFIRST CORP MASS | UNF | $1.6M | 6,071 | -0.10pp | 2q | +102.4%+$812.2K | |
| BIOLIFE SOLUTIONS INC OPT | BLFS | $1.5M | 32,000 | - | new | NEW | |
| REVOLUTION MEDICINES INC | RVMD | $1.4M | 7,221 | -0.37pp | 2q | -24.2%-$431.3K | |
| IONQ INC OPT | IONQ | $1.3M | options only | - | new | OPTIONS | |
| CAESARS ENTERTAINMENT INC NE | CZR | $1.3M | 44,000 | - | new | NEW | |
| AVANOS MED INC | AVNS | $1.2M | 47,600 | - | new | NEW | |
| PAYONEER GLOBAL INC OPT | PAYO | $1.2M | 145,000 | - | new | NEW | |
| CYTOKINETICS INC | CYTK | $1.1M | 12,400 | +0.06pp | 11q | +12.7%+$119.3K | |
| CECO ENVIRONMENTAL CORP | CECO | $927.2K | 10,218 | +0.13pp | 2q | +27.7%+$201.3K | |
| NCR ATLEOS CORPORATION | NATL | $868.2K | 20,000 | - | new | NEW | |
| ROKU INC | ROKU | $828.8K | 6,000 | - | new | NEW | |
| REPLIGEN CORP OPT | RGEN | $723.1K | options only | - | new | OPTIONS | |
| ABIVAX SA OPT | ABVX | $706.3K | 2,800 | - | new | NEW | |
| SILICON MOTION TECHNOLOGY CO | SIMO | $643.3K | 1,930 | +0.09pp | 4q | -34.6%-$340.0K | |
| ESPERION THERAPEUTICS INC NE | ESPR | $632.0K | 200,000 | - | new | NEW | |
| NVIDIA CORPORATION | NVDA | $506.8K | 2,533 | flat | 8q | +7.9%+$37.2K | |
| VIAVI SOLUTIONS INC | VIAV | $465.4K | 9,747 | +0.03pp | 2q | HELD | |
| COMMVAULT SYS INC | CVLT | $453.5K | 3,200 | - | new | NEW | |
| STELLAR BANCORP INC | STEL | $416.7K | 10,598 | -1.40pp | 2q | -88.0%-$3.0M | |
| ALPHABET INC | GOOG | $409.9K | 1,160 | - | new | NEW | |
| BOEING CO | BA | $389.6K | 1,800 | -0.52pp | 3q | -48.6%-$367.9K | |
| SUPERNUS PHARMACEUTICALS | SUPN | $376.7K | 8,100 | -0.03pp | 4q | +14.1%+$46.5K | |
| LIGAND PHARMACEUTICALS INC | LGND | $347.7K | 1,100 | - | new | NEW | |
| SELECT MED HLDGS CORP | SEM | $346.7K | 21,000 | -0.02pp | 3q | +6.6%+$21.5K | |
| ON SEMICONDUCTOR CORP | ON | $330.9K | 3,500 | - | new | NEW | |
| DOMINION ENERGY INC | D | $273.2K | 4,000 | - | new | NEW | |
| NEUROCRINE BIOSCIENCES INC | NBIX | $272.5K | 1,617 | - | new | NEW | |
| ANALOG DEVICES INC | ADI | $270.5K | 681 | flat | 2q | HELD | |
| INHIBRX BIOSCIENCES INC | INBX | $246.3K | 2,600 | - | new | NEW | |
| HUNTSMAN CORP | HUN | $159.3K | 15,000 | - | new | NEW | |
| GEOPARK LTD | GPRK | $152.9K | 16,800 | -0.17pp | 3q | -66.4%-$302.1K | |
| CERTARA INC | CERT | $131.0K | 20,000 | - | new | NEW | |
| LUMEN TECHNOLOGIES INC | LUMN | $96.3K | 12,540 | flat | 21q | HELD |
By sector
Industry comes from the SIC code on each company's own SEC filings, which is self-reported and sometimes out of date. Derivative exposure is counted with the shares. Securities the SEC assigns no industry - funds, trusts, foreign issues - are shown as not classified rather than dropped.
| Sector | Value | Share |
|---|---|---|
| Software & IT Services | $45.4M | 17.8% |
| Biotech & Pharma | $29.7M | 11.7% |
| Telecom & Media | $29.2M | 11.5% |
| Medical Devices | $19.6M | 7.7% |
| Transport & Logistics | $15.8M | 6.2% |
| Semiconductors & Electronics | $6.2M | 2.4% |
| Business Services | $6.1M | 2.4% |
| Other sectors | $12.7M | 5.0% |
| Not classified | $89.6M | 35.2% |
Quarter by quarter
| Quarter | Value | Positions | New | Added | Trimmed | Exited | Top 10 | Days to file |
|---|---|---|---|---|---|---|---|---|
| Q2 2026 | $254.5M | 55 | 32 | 12 | 8 | 26 | 74.6% | 45 |
| Q1 2026 | $206.4M | 49 | 27 | 2 | 17 | 32 | 76.3% | 45 |
| Q4 2025 | $312.0M | 54 | 29 | 12 | 7 | 27 | 78.6% | 48 |
| Q3 2025 | $231.3M | 52 | 33 | 13 | 3 | 29 | 74.0% | 45 |
| Q2 2025 | $235.0M | 48 | 29 | 12 | 4 | 31 | 74.5% | 45 |
| Q1 2025 | $226.4M | 50 | 27 | 11 | 9 | 23 | 73.5% | 45 |
| Q4 2024 | $207.1M | 46 | 27 | 9 | 6 | 25 | 72.9% | 45 |
| Q3 2024 | $196.7M | 44 | 16 | 12 | 9 | 14 | 69.3% | 45 |
| Q2 2024 | $131.0M | 42 | 23 | 9 | 6 | 18 | 65.1% | 45 |
| Q1 2024 | $148.3M | 37 | 18 | 9 | 6 | 19 | 74.6% | 45 |
| Q4 2023 | $108.1M | 38 | 20 | 8 | 8 | 24 | 76.4% | 45 |
| Q3 2023 | $192.3M | 42 | 19 | 10 | 4 | 13 | 86.2% | 45 |
| Q2 2023 | $115.9M | 36 | 17 | 8 | 6 | 20 | 81.4% | 20 |
| Q1 2023 | $132.4M | 39 | 23 | 7 | 6 | 18 | 77.4% | 45 |
| Q4 2022 | $96.7M | 34 | 15 | 10 | 7 | 31 | 70.1% | 45 |
| Q3 2022 | $123.9M | 50 | 27 | 6 | 7 | 20 | 62.4% | 45 |
| Q2 2022 | $86.7M | 43 | 20 | 9 | 11 | 22 | 66.2% | 46 |
| Q1 2022 | $114.3M | 45 | 21 | 10 | 12 | 19 | 61.2% | 46 |
| Q4 2021 | $171.1M | 43 | 21 | 8 | 10 | 24 | 78.1% | 45 |
| Q3 2021 | $146.8M | 46 | 22 | 14 | 3 | 22 | 66.3% | 35 |
| Q2 2021 | $154.2M | 46 | 23 | 8 | 8 | 30 | 72.4% | 23 |
| Q1 2021 | $167.1M | 53 | 36 | 8 | 7 | 19 | 57.7% | 34 |
| Q4 2020 | $122.8M | 36 | 18 | 10 | 5 | 14 | 76.5% | 34 |
| Q3 2020 | $91.0M | 32 | 16 | 12 | 1 | 7 | 79.1% | 23 |
| Q2 2020 | $28.0M | 23 | 8 | 5 | 3 | 12 | 82.5% | 45 |
| Q1 2020 | $61.8M | 27 | 9 | 8 | 7 | 20 | 82.8% | 28 |
| Q4 2019 | $50.4M | 38 | 20 | 7 | 7 | 23 | 68.1% | 38 |
| Q3 2019 | $71.8M | 41 | 18 | 9 | 7 | 25 | 70.0% | 30 |
| Q2 2019 | $72.8M | 48 | 24 | 4 | 8 | 20 | 72.1% | 24 |
| Q1 2019 | $68.3M | 44 | 28 | 11 | 2 | 9 | 74.8% | 24 |
| Q4 2018 | $62.1M | 25 | 0 | 0 | 0 | 0 | 91.7% | 42 |
Rows marked UNVERIFIED ID, PLACEHOLDER ID, TICKER AS ID or NON-CUSIP ID carry an identifier that is not a valid CUSIP. They are shown because the filer reported that money, but treat the security named with caution - hover the chip for what is wrong with it, and see the methodology.
Held counts consecutive filings in which this manager reported the position, and can reach further back than the quarters listed above: the tabs begin at Q4 2018 because earlier coverage is too sparse to describe a market, but tenure is counted over every filing we hold, some reaching to 2007. A position sold and later rebought starts again from one.
Weight change is the shift in this position's share of the whole book, in percentage points. It is the more useful column: when money flows into or out of a broad fund, almost every holding is bought or sold at once, so added and trimmed largely track flows. A weight that rose while the book shrank is a decision. Both compare with the previous quarter this filer reported, not the previous calendar quarter.